HealthTechCrunch — Page 3

Medicare's 1965 statute lacks a benefit category for software, leaving PDTs in limbo.

Independent testing reveals accuracy gaps manufacturers' studies don't show.

De Novo clears the first product; 510(k) clears everything after that.

Health systems evaluate cleared digital therapeutics like medical devices, not software.

Most healthcare websites still run tracking tools that violate HIPAA's rules.

Multiple agencies share authority over pharma marketing with overlapping jurisdiction.

Most healthcare content ROI models measure only the final click, missing the entire patient journey.

Most patient decisions happen online before they ever call a doctor.

Skeptical consumers demand evidence, not wellness marketing hype.

Separate your marketing into two distinct tracks: one for families, one for referral partners.

Compliance risk and tight budgets demand upfront strategic clarity, not post-campaign adjustments.